Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:07 PM
Ignite Modification Date:
2025-12-24 @ 9:07 PM
NCT ID:
NCT01570504
Eligibility Criteria:
Inclusion Criteria:
* Male and female patients older than 5 years and weighting \> 15 kg
* Current residence in non-endemic areas
* Either direct diagnosis of S. stercoralis infection AND positive serology at any titer OR positive serology at "high" titer, irrespective of results of direct tests
Exclusion Criteria:
* Pregnant or lactating women
* Subjects suffering from CNS diseases
* Disseminated strongyloidiasis
* Immunocompromised patients.
* Lack of informed consent
* Previous treatment with ivermectin (in the last year)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Years
Study:
NCT01570504
Study Brief:
Protocol Section:
NCT01570504